Skip navigation
  •  Home
  • UDC 
    • Getting started
    • RUC Policies
    • FAQ
    • FAQ on Copyright
    • More information at INFOguias UDC
  • Browse 
    • Communities
    • Browse by:
    • Issue Date
    • Author
    • Title
    • Subject
  • Help
    • español
    • Gallegan
    • English
  • Login
  •  English 
    • Español
    • Galego
    • English
  
View Item 
  •   DSpace Home
  • Facultade de Ciencias da Saúde
  • Investigación (FCS)
  • View Item
  •   DSpace Home
  • Facultade de Ciencias da Saúde
  • Investigación (FCS)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Characterization of chronic HCV infection in Northwest Spain: impact of the treatment strategic plan of the Spanish National Health Service on HCV cure

Thumbnail
View/Open
Grandal_Characterization.pdf (239.3Kb)
Use this link to cite
http://hdl.handle.net/2183/18625
Collections
  • Investigación (FCS) [1293]
Metadata
Show full item record
Title
Characterization of chronic HCV infection in Northwest Spain: impact of the treatment strategic plan of the Spanish National Health Service on HCV cure
Author(s)
Grandal, Marta
Pernas, Berta
Mariño, Ana
Álvarez, Hortensia
Tabernilla, Andrés
Castro-Iglesias, Ángeles
Mena, Álvaro
Delgado, Manuel
Pértega-Díaz, Sonia
Poveda, Eva
Date
2017-03-14
Citation
Grandal M, Pernas B, Mariño A, et al. Characterization of chronic HCV infection in Northwest Spain: impact of the treatment strategic plan of the Spanish National Health Service on HCV cure. J Med Virol. 2017;89(7):1304-1308
Abstract
[Abstract] The aim of the study was to characterize HCV infection in Northwest Spain and assess the impact of the Spanish Strategic Plan to cure HCV infection. Overall, 387 patients were included (60.9% HIV/HCV coinfected and 28.2% cirrhotic). Of these, 72.9% of patients that were recognized as priority for HCV treatment according to the Spanish Strategic Plan (≥F2, transplant or extrahepatic manifestations), initiated treatment during 2015. Globally, SVR12 was achieved in 96.5% of patients. The implementation of the Spanish Strategic Plan has been critical to advance in HCV cure, but 27.1% of priority patients still remain awaiting HCV treatment initiation.
Keywords
HCV infection
HCV treatment
HIV/HCV coinfection
 
Editor version
http://dx.doi.org/10.1002/jmv.24766
Rights
This is the peer reviewed version of the article which has been published in final form at Wiley Online Library. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archiving
ISSN
0146-6615
1096-9071
 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsResearch GroupAcademic DegreeThis CollectionBy Issue DateAuthorsTitlesSubjectsResearch GroupAcademic Degree

My Account

LoginRegister

Statistics

View Usage Statistics
Sherpa
OpenArchives
OAIster
Scholar Google
UNIVERSIDADE DA CORUÑA. Servizo de Biblioteca.    DSpace Software Copyright © 2002-2013 Duraspace - Send Feedback